EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-21298 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr16:67425020-67426840 
Target genes
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Klf12MA0742.1chr16:67425991-67426006GGCCACGCCCTGAAC+6.1
Klf1MA0493.1chr16:67426246-67426257GGCCACACCCT+6.32
Klf1MA0493.1chr16:67426447-67426458GGCCACACCCT+6.32
PLAG1MA0163.1chr16:67425759-67425773GGGGCCCACGGGTG+6.72
ZNF263MA0528.1chr16:67425866-67425887GGGGGAGCAGGAGGTTGGGGG+6.34
ZNF263MA0528.1chr16:67426560-67426581CCCTCCTCCACTGCCACCTCC-6.41
ZNF263MA0528.1chr16:67426548-67426569CCCACCACATCCCCCTCCTCC-7.01
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_24356chr16:67425062-67426456Colon_Crypt_2
SE_24356chr16:67426631-67428127Colon_Crypt_2
SE_29769chr16:67423083-67435735Fetal_Muscle
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr166742519167425854
Enhancer Sequence
CTATAGAGAC CCACCTGGGT CATCTCCCAG CCAATCTGCC CTTCCCCTCC CCCAAGCCCA 60
GAACATCCCA GCCTCTACCT CAAACCTGCA AGACCTGGGC AGGTTCTGCT ACAGAGTTGG 120
TGCTGGAGCT GCCTGGGGAG AGGGGCCCGT CACTGTCGCC CTGGGCCACA GAGCCCCAAG 180
GAAGAGCCCC GGGAGGCACG GTCTTGTCAC TAATGCCAGC CCTGGCTCTC AGCAGGGTTC 240
AGCAGATGAA ATAATGATGC CCACAGGGAA CAGAGTGGCA CTGTCCAGAA AGACTGTTAG 300
GGCAGCAGCT GGGGCCCTGG CTTTGTCTGG CCCTGGCACA AGGCCTTGCT TGGGTGGAAG 360
TGAGGGTGGC AGAGCAGGCC CCCTCCCTGG AAGCTCCATG CCAAGCTGGC TTGGGGCCAG 420
GCCAGGCTGC TGGTCGGGCA GGCATTCAGT GAGGACAGCA TCTCTGTAAG GGTCATGAGG 480
ACCCAGCAAG AGCCAGTCTG GGCACGGGTG CATGCCCTGG GCAGGGGTGC AGCTGGTCCA 540
GCAAGGCCTT GTTACTATTT GCTGTTAAAC AAAAACATGA GGGGAGCTTG GGGCTGGCCT 600
GGCCACAGTT TGTGAAGCCT GGAGACGGTT GCTAAGGGAG GGTGGTGCTG CTTGGAGAAT 660
GTTGCTAAGG GCAGGATGGT GTCAGGGCAG CTCAGGGAGA AGCTCCCAGT GCTGAGGGGC 720
TGGGCTGGGC TGGGAAGCTG GGGCCCACGG GTGGGGCACG CCAGCACTCC CTGCGCCTAG 780
GGCATAACCG TGGCTTCCTG GCCCCTTGCC ACCGACTGGT GCTGTAACCT CCCACTGTGG 840
AGTTTTGGGG GAGCAGGAGG TTGGGGGCTA GTAGCGTGGG GGCTGTAGAG TTACGAACCC 900
CAAGAGTCGT GCTGGCAAGT GGGGCTGTGG CTGAAACACA CTTCATCATG TCTACACCTC 960
AGACCTCCCC TGGCCACGCC CTGAACTTGG CCACACCAGC CCACATTCCC AGCGACCCTG 1020
TGCACTCAGC CCTGGCCTGC CACCCCCTGG GCCTTGTACC CCTGGCCATA CCTTCAGCCC 1080
TCCATCCTCC ATCTTCACAC CCACAGCCAC AGCCCTCGGC CACCAGCCCC CACATATATA 1140
CTAACAAGCC TGCGCCAACC CCAGTAATAC CCACAGTCCA GCACTAAAGT GCCCCCCACA 1200
CCCACAGCCC TCCGCTGCAG ACCCCTGGCC ACACCCTGAG CCTACACAGC AGCCTTCTCC 1260
ATCCCCACAC CCGCAGCCCT GGGGCTGAGG CCCCTGGCCA CAAACCTGCA TCCCTTCCTG 1320
AGACCCCTGA CCATAGCCTC AGCCACTCAC CCCCTCCAAT ACCCGCAGCC CTTTATCAAG 1380
GCGCCCTGAC CCTCAGCACC CCTTTGTCCA CACACCCTCA GCCCTCTGGC CACACCCTCA 1440
GCCTGCACTG AAGGCCCCAG TCCACATCCA CACACTAACA TTATAAGACT CCCAGGTACT 1500
ATGCGGAGAT CCCCTGCGTA GAGACCTCCC CACCACATCC CCCTCCTCCA CTGCCACCTC 1560
CTGACCACAC CCTCGGTCTC AGCAACCATC TTCTAGCTCT GCCTTTTACA CTAGGGCTTC 1620
CAGTGACCAC GGCCTGGGCT CTGCCCGGCT GCCCCATCTT CCACCAAAAA CTCCTCGCCA 1680
GTGACCACAC TCCCATCCCT AAGTGGCAGT TTCTGGGACT GTGAGCACCG GTGGTTCCTA 1740
CGTTACAGGG ACCATAACCC CAGTCCACGC TGCACTCCCC TTCCCTTTCC CTGGGTGCAA 1800
CCTCCCACCA GGGACCCCAA 1820